We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BERKELEY, Calif., Sept. 8, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMAD), a leader in the discovery and development of therapeutic antibodies, today announced that company management will...
BERKELEY, Calif., Sept. 2, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMAD), a leader in the discovery and development of therapeutic antibodies, today announced that NASDAQ has notified the...
BERKELEY, Calif., Aug. 26, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMAD), a leader in the discovery and development of antibody therapeutics, announced that Jack L. Wyszomierski, a seasoned...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions